Find News

Filter articles

Showing 1 to 10 of 1611 results

Thermo Fisher dismisses patent action against DeNovix


Biotech company Thermo Fisher Scientific has dismissed its patent infringement action against DeNovix, US-based instrumentation business.

Merck CEO resigns from Trump’s manufacturing council


Kenneth Frazier, the CEO of Merck, is one of three chief executives to step down from US President Donald Trump’s manufacturing council.

Pfizer’s patents for overactive bladder drug not obvious, rules US judge


A US judge has ruled that five patents owned by Pfizer are not invalid as obvious, in a dispute over a generic produced by Mylan.

Jazz takes on Novartis over sound of trademark


Jazz Pharmaceuticals has taken issue with a trademark application filed by Novartis in the US, filing an opposition at the Trademark Trial and Appeal Board.

Federal Circuit rejects Amgen biosimilar discovery request


The US Court of Appeals for the Federal Circuit has rejected a request by Amgen to compel discovery from Hospira over a biosimilar.

USITC begins probe into CSL Behring


The US International Trade Commission has instituted a probe into CSL Behring, a biopharmaceutical company.

Big pharma faces little competition in Mexico, says competition agency


Big pharma is confronted with little competition in Mexico, with 22 drugs facing no generic rivals in the country.

FDA finalises 46 bioequivalence guidelines in August


The US Food and Drug Administration finalised 46 product-specific bioequivalence guidances in August. 

Dermira acquires licensing rights to Roche dermatitis drug


Biopharmaceutical company Dermira has acquired the licensing rights to lebrikizumab, a treatment for atopic dermatitis, from Roche.

Coherus seeks IPR of Amgen patent


Biopharma company Coherus BioSciences has filed a petition for inter partes review of a patent controlled by Amgen.

Showing 1 to 10 of 1611 results